Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|3|387-391

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.3, 2011-03, pp. : 387-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: New Perspectives in the Treatment of Hematological Malignancies (Guest Editor: Masahiro Kizaki)]

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-01 ,pp. : 313-313

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic:Strategies for Molecular-Based Treatment of Hematological Malignancies (Guest Editor: Per Ole Iversen)]

By  

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 629-629

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Hot Topic: Highlights on Important Signaling Pathways as Drug Targets in Hematological Malignancies (Guest Editors: H. Serve and H.C. Hasselbalch) ]

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 203-203

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Overview of Antiangiogenic Therapies in Hematological Malignancies (Guest Editor: D. Ribatti)]

By  

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 995-996

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: New and Emerging Drug Targets for the Treatment of Hematological Malignancies (Guest Editors: Dr. Linda J. Bendall)]

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 767-768

Bentham Science Publishers

Access to resources Recommend Favorite